Medtronic Plc (NYSE:MDT) shares traded 0.66% higher at $85.38 on Wall Street last session.
MDT stock price is now 6.41% away from the 50-day moving average and 4.37% away from the 200-day moving average. The market capitalization of the company currently stands at $109.51B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $76 to $90, UBS Upgraded its rating from Sell to Neutral for Medtronic Plc (NYSE: MDT). On August 14, 2024, Stifel Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $100 to quote $85, while ‘Goldman’ rates the stock as ‘Sell’
In other news, Martha Geoffrey, Chairman and CEO sold 19,113 shares of the company’s stock on Jun 07 ’24. The stock was sold for $1,601,001 at an average price of $83.77. Upon completion of the transaction, the Chairman and CEO now directly owns 143,348 shares in the company, valued at $12.24 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 08 ’24, EVP & President, Surgical OU Marinaro Michael sold 854 shares of the business’s stock. A total of $71,002 was realized by selling the stock at an average price of $83.14. This leaves the insider owning 27,925 shares of the company worth $2.38 million. A total of 0.16% of the company’s stock is owned by insiders.
During the past 12 months, Medtronic Plc has had a low of $68.84 and a high of $89.18. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 2.13, and a quick ratio of 1.61. According to the stock market information, the enterprise value for the company is $127728197632, which is based on a 28.76 price-to-earnings ratio, a 6.53 price-to-earnings-growth ratio, and a beta of 0.85. The fifty day moving average price for MDT is $80.2666 and a two-hundred day moving average price translates $81.87455 for the stock.
The latest earnings results from Medtronic Plc (NYSE: MDT) was released for 2024-04-26. The net profit margin was 12.05% and return on equity was 7.93% for MDT. The company reported revenue of $8.59 billion for the quarter, compared to $8.54 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 0.53 percent.
